Upstream Bio Stock

upstreambio.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $400MM

Upstream Bio, founded in 2021, is a biotechnology company with the goal of advancing the medical field through genetic technologies and computational methods. Their work predominantly revolves around aiming to develop novel therapeutics for challenging diseases, pushing boundaries in personalized medicine and genomics, and striving for breakthroughs that could significantly enhance human health and lifespan.

Register To Buy and Sell Shares

For more details on financing and valuation for Upstream Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Upstream Bio’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Upstream Bio.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Upstream Bio’s Stock

Can you buy Upstream Bio’s stock?
Upstream Bio is not publicly traded on NYSE or NASDAQ in the U.S. To buy Upstream Bio’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Upstream Bio’s stock?
Yes, you can sell stock of a private company like Upstream Bio. Forge can help you sell your Upstream Bio stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Upstream Bio’s stock price?
Upstream Bio is a privately held company and therefore does not have a public stock price. However, you may access Upstream Bio’s private market stock price with Forge Data.
What is Upstream Bio’s stock ticker symbol?
Upstream Bio does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
Upstream Bio, a clinical-stage biotech company advancing new therapies to treat inflammation, today announced the completion of a $200 million Series B financing.
Updated on: Apr 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.